DaVita's Q3 earnings miss expectations, leading to a decline in share price, as the company faces cost and volume headwinds despite pockets of growth.
Pfizer sues Novo Nordisk to block its $8.5-$9B bid for Metsera, alleging antitrust violations and a 'kill' strategy to preserve dominance in GLP-1 obesity drugs.
Brissett to start for Cardinals as they visit Cowboys amid trade buzz ahead of NFL deadline
DaVita's Q3 earnings miss expectations, leading to a decline in share price, as the company faces cost and volume headwinds despite pockets of growth.
Pfizer sues Novo Nordisk to block its $8.5-$9B bid for Metsera, alleging antitrust violations and a 'kill' strategy to preserve dominance in GLP-1 obesity drugs.
Brissett to start for Cardinals as they visit Cowboys amid trade buzz ahead of NFL deadline